142 related articles for article (PubMed ID: 38069245)
21. Two anonymous DNA segments distinguish the Wilms' tumor and aniridia loci.
Davis LM; Stallard R; Thomas GH; Couillin P; Junien C; Nowak NJ; Shows TB
Science; 1988 Aug; 241(4867):840-2. PubMed ID: 2841760
[TBL] [Abstract][Full Text] [Related]
22. An uncommon presentation of WAGR syndrome with persistent fetal vasculature.
Devaraj A; Shetty S; Patnaik N; Parida H; Pandurangan S
J AAPOS; 2023 Dec; 27(6):357-359. PubMed ID: 37742703
[TBL] [Abstract][Full Text] [Related]
23. Polymerase chain reaction-based risk assessment for Wilms tumor in sporadic aniridia.
Gupta SK; De Becker I; Guernsey DL; Neumann PE
Am J Ophthalmol; 1998 May; 125(5):687-92. PubMed ID: 9625553
[TBL] [Abstract][Full Text] [Related]
24. WAGR syndrome with deletion of chromosome 11p11.2-13.
Pinna A; Carta A; Mannazzu MC; Dore S; Balata A; Carta F
J AAPOS; 2004 Aug; 8(4):396-7. PubMed ID: 15314606
[No Abstract] [Full Text] [Related]
25. Prediction by FISH analysis of the occurrence of Wilms tumor in aniridia patients.
Muto R; Yamamori S; Ohashi H; Osawa M
Am J Med Genet; 2002 Apr; 108(4):285-9. PubMed ID: 11920832
[TBL] [Abstract][Full Text] [Related]
26. The beta-subunit of follicle-stimulating hormone is deleted in patients with aniridia and Wilms' tumour, allowing a further definition of the WAGR locus.
Glaser T; Lewis WH; Bruns GA; Watkins PC; Rogler CE; Shows TB; Powers VE; Willard HF; Goguen JM; Simola KO
Nature; 1986 Jun 26-Jul 2; 321(6073):882-7. PubMed ID: 3014343
[TBL] [Abstract][Full Text] [Related]
27. WAGR syndrome--a case report.
Mahale A; Poornima V; Shrestha M
Nepal Med Coll J; 2007 Jun; 9(2):138-40. PubMed ID: 17899969
[TBL] [Abstract][Full Text] [Related]
28. Billateral polycystic kidneys in a girl with WAGR syndrome.
Gucev Z; Muratovska O; Laban N; Misevska L; Jancevska A; Crolla J; Tasic V
Indian J Pediatr; 2011 Oct; 78(10):1290-2. PubMed ID: 21660403
[TBL] [Abstract][Full Text] [Related]
29. [Aniridia and Wilms tumor: 2 cases of fetal rhabdomyomatous nephroblastoma].
Schneider P; Drouin-Garraud V; Bachy B; Brasseur G; Lahsinat K; Hemet J; Vannier JP; Tron P
Arch Pediatr; 1996 Dec; 3(12):1243-7. PubMed ID: 9033789
[TBL] [Abstract][Full Text] [Related]
30. [Multicystic renal tumor in a patient with WAGR syndrome].
Braun KP; May M; Erler T; Hoschke B
Urologe A; 2007 Jun; 46(6):671-4. PubMed ID: 17295033
[TBL] [Abstract][Full Text] [Related]
31. LMO2 gene deletions significantly worsen the prognosis of Wilms' tumor development in patients with WAGR syndrome.
Marakhonov AV; Vasilyeva TA; Voskresenskaya AA; Sukhanova NV; Kadyshev VV; Kutsev SI; Zinchenko RA
Hum Mol Genet; 2019 Oct; 28(19):3323-3326. PubMed ID: 31304537
[TBL] [Abstract][Full Text] [Related]
32. Homozygous inactivation of WT1 in a Wilms' tumor associated with the WAGR syndrome.
Gessler M; König A; Moore J; Qualman S; Arden K; Cavenee W; Bruns G
Genes Chromosomes Cancer; 1993 Jul; 7(3):131-6. PubMed ID: 7687865
[TBL] [Abstract][Full Text] [Related]
33. Submicroscopic deletions at the WAGR locus, revealed by nonradioactive in situ hybridization.
Fantes JA; Bickmore WA; Fletcher JM; Ballesta F; Hanson IM; van Heyningen V
Am J Hum Genet; 1992 Dec; 51(6):1286-94. PubMed ID: 1334370
[TBL] [Abstract][Full Text] [Related]
34. Evaluation of chromosome 11p imbalances in aniridia and Wilms tumor patients.
Busch M; Leube B; Thiel A; Schanze I; Beier M; Royer-Pokora B
Am J Med Genet A; 2013 May; 161A(5):958-64. PubMed ID: 23494989
[TBL] [Abstract][Full Text] [Related]
35. [WAGR syndrome: a case report].
Moreno García M; Sánchez del Pozo J; Fernández Martínez FJ; Moreno-Izquierdo A; Barreiro Miranda E
An Esp Pediatr; 1998 Oct; 49(4):381-7. PubMed ID: 9859552
[TBL] [Abstract][Full Text] [Related]
36. Molecular mapping and cloning of the breakpoints of a chromosome 11p14.1-p13 deletion associated with the AGR syndrome.
Gessler M; Bruns GA
Genomics; 1988 Aug; 3(2):117-23. PubMed ID: 2852160
[TBL] [Abstract][Full Text] [Related]
37. Population-based risk estimates of Wilms tumor in sporadic aniridia. A comprehensive mutation screening procedure of PAX6 identifies 80% of mutations in aniridia.
Grønskov K; Olsen JH; Sand A; Pedersen W; Carlsen N; Bak Jylling AM; Lyngbye T; Brøndum-Nielsen K; Rosenberg T
Hum Genet; 2001 Jul; 109(1):11-8. PubMed ID: 11479730
[TBL] [Abstract][Full Text] [Related]
38. Molecular analysis of a reciprocal translocation t(5;11) (q11;p13) in a WAGR patient.
Puissant H; Azoulay M; Serre JL; Piet LL; Junien C
Hum Genet; 1988 Jul; 79(3):280-2. PubMed ID: 2841227
[TBL] [Abstract][Full Text] [Related]
39. Altered trans-activational properties of a mutated WT1 gene product in a WAGR-associated Wilms' tumor.
Park S; Tomlinson G; Nisen P; Haber DA
Cancer Res; 1993 Oct; 53(20):4757-60. PubMed ID: 8402654
[TBL] [Abstract][Full Text] [Related]
40. Molecular analysis of aniridia patients for deletions involving the Wilms' tumor gene.
Drechsler M; Meijers-Heijboer EJ; Schneider S; Schurich B; Grond-Ginsbach C; Tariverdian G; Kantner G; Blankenagel A; Kaps D; Schroeder-Kurth T
Hum Genet; 1994 Oct; 94(4):331-8. PubMed ID: 7927324
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
